David Mannino, MD, is the chief medical officer on the COPD Basis. He has a protracted historical past of analysis and engagement in respiratory well being.
After finishing medical coaching as a pulmonary care specialist, Dr. Mannino joined the Facilities for Illness Management and Prevention (CDC) Air Air pollution and Respiratory Well being Department. Whereas at CDC, he helped to develop the Nationwide Bronchial asthma Program and led efforts on the Surveillance Stories that described the U.S. burden of bronchial asthma (1998) and COPD (2002).
After his retirement from CDC in 2004, Mannino joined the school on the College of Kentucky, the place he was concerned each clinically within the School of Medication and as a trainer, researcher, and administrator within the School of Public Well being. He served as professor and chair within the division of preventive drugs and environmental well being from 2012 to 2017, with a joint appointment within the division of epidemiology.
In 2004, Mannino helped to launch the COPD Basis, the place he served as a board member from 2004 by means of 2015, chairman of the Medical and Scientific Advisory Committee from 2010 by means of 2015, and chief scientific officer from 2015 to 2017.
Mannino has over 350 publications and serves as an affiliate editor or editorial board member for the next journals: American Journal of Respiratory and Crucial Care Medication, Chest, Thorax, European Respiratory Journal, and the Journal of the COPD Basis. He was additionally a coauthor of the Surgeon Common’s Report on Tobacco in 2008 and 2014.
